Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03743779 · ClinicalTrials.gov registry record
Mastering Diabetes Pilot Study
A clinical trial, sponsored by Ohio University.
- Completed
- Registry status
- 253
- Enrollment target
NCT03743779: Completed study, sponsored by Ohio University.
NCT03743779 is a clinical trial that has completed, run by Ohio University. The registered enrollment target is 253 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03743779 has completed, sponsored by Ohio University.
- COMPLETED
- Registry status
- 253 participants
- Enrollment target
Study Summary
This is a pilot study looking at past results of the Mastering Diabetes program utilizing a survey.
Primary Outcome
change in glycosylated hemoglobin during program
Interventions
- BEHAVIORAL Mastering Diabetes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 253 participants |
| Start Date | 2018-09-09 |
| Est. Completion | 2019-07-01 |
What the finished NCT03743779 record still lists
NCT03743779 is an observational study that tracks outcomes without assigning an intervention. The registered 253 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Mastering Diabetes is the first listed.
NCT03743779 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03743779 about?
NCT03743779 is a clinical study titled "Mastering Diabetes Pilot Study". This is a pilot study looking at past results of the Mastering Diabetes program utilizing a survey.
What is the current status of trial NCT03743779?
This trial is currently completed. The enrollment target is 253 participants. The study started on 2018-09-09. Estimated completion is 2019-07-01.
What interventions are being tested in trial NCT03743779?
The interventions under investigation include: Mastering Diabetes (BEHAVIORAL).
Who is sponsoring clinical trial NCT03743779?
This trial is sponsored by Ohio University, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04390737 · 254 participants · Phase 1
Evaluate the Safety and Clinical Activity of HH2853
- NCT04677647 · 254 participants · NA
OurChild: A Health IT Solution to Reduce Minority Health Disparities
- NCT05503797 · 254 participants · Phase 2
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- NCT06167317 · 254 participants · Phase 1
Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI